Efficacy and safety of 48 weeks of treatment with octreotide LAR in newly diagnosed acromegalic patients with macroadenomas: an open-label, multicenter, non-comparative study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples